---
title: "SNSE.US (SNSE.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SNSE.US/news.md"
symbol: "SNSE.US"
name: "SNSE.US"
parent: "https://longbridge.com/en/quote/SNSE.US.md"
datetime: "2026-05-21T14:27:51.509Z"
locales:
  - [en](https://longbridge.com/en/quote/SNSE.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNSE.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNSE.US/news.md)
---

# SNSE.US (SNSE.US) — Related News

### [Sensei Biotherapeutics (NASDAQ:SNSE) Major Shareholder Millennium Management Llc Sells 8,151 Shares](https://longbridge.com/en/news/286644511.md)
*2026-05-16T11:43:57.000Z*
> Millennium Management LLC, a major shareholder of Sensei Biotherapeutics (NASDAQ:SNSE), sold 8,151 shares at an average 

### [12 Health Care Stocks Moving In Friday's After-Market Session](https://longbridge.com/en/news/286619566.md)
*2026-05-15T21:06:26.000Z*
> In Friday's after-market session, Accuray (ARAY) shares surged 39% to $0.38, while Sensei Biotherapeutics (SNSE) rose 14

### [Sensei Biotherapeutics reports $170.2M Q1 net loss, $202.8M cash position](https://longbridge.com/en/news/286559285.md)
*2026-05-15T11:43:00.000Z*
> Sensei Biotherapeutics reported a Q1 2026 net loss of $170.2 million, or $131.45 per share, due to one-time charges from

### [Sensei Biotherapeutics | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286557759.md)
*2026-05-15T11:36:54.000Z*
### [Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | SNSE Stock News](https://longbridge.com/en/news/286556671.md)
*2026-05-15T03:30:29.000Z*
> Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | SNSE Stock News

### [03:40 ETSenhwa Biosciences Launches Global Study, Targeting Breakthrough in Hard-to-Treat Cancers with CX-5461 and Tislelizumab Combination](https://longbridge.com/en/news/285168369.md)
*2026-05-05T07:42:19.000Z*
> Senhwa Biosciences, Inc. has launched a global clinical trial for its investigational drug CX-5461, in combination with 

### [](https://longbridge.com/en/news/285110311.md)
*2026-05-04T19:26:56.000Z*
> According to the latest data, the stocks with the highest short interest in the U.S. healthcare sector at the beginning 

### [May Healthcare Stock Long and Short Rankings: Sensei and KalVista Lead in Short Interest](https://longbridge.com/en/news/285110271.md)
*2026-05-04T19:25:38.000Z*
> As April comes to an end, short interest in small-cap healthcare stocks with a market capitalization below $2 billion ha